Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban Dose-Ranging in Total Hip Arthroplasty
NCT00107900Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2005
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edoxaban in venous thromboembolism (VTE), sponsored by Daiichi Sankyo Co., Ltd.. Started Jan 2005; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00107900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107900.